Simran Agrovet IPO GMP Today, Price & Details
Simran Agrovet IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Simran Agrovet
Simran Agrovet is poised to enter the market through an SME IPO on the NSE, aiming to raise ₹6435000 Cr. The company operates within the agrochemical sector, a vital industry supporting India's agricultural backbone. With reported revenues of ₹566.31 Cr, Simran Agrovet demonstrates a significant scale of operations within its domain.
The IPO comprises entirely of a fresh issue, indicating that the capital raised will be injected directly into the company for future growth initiatives, rather than promoters cashing out their stake. This fresh capital is expected to fuel expansion plans and strengthen the company's position in the competitive agrochemical landscape. While specific details regarding employee count or a comprehensive history of its competitive positioning are not provided in the data, the substantial revenue figure suggests an established presence.
The company's profitability, reflected in a Profit After Tax (PAT) of ₹11.13 Cr, indicates its ability to generate earnings from its operations. The IPO's success will hinge on its ability to leverage this capital effectively to enhance its product offerings and market reach.
Simran Agrovet IPO — Investment Analysis
Simran Agrovet's IPO presents a valuation that warrants careful consideration. The Price-to-Earnings (P/E) ratio stands at 13.15x, based on an Earnings Per Share (EPS) of ₹9.28. To assess its reasonableness, one would typically compare this to the P/E multiples of similar listed agrochemical companies.
Without this comparative data, it's difficult to definitively label the valuation as cheap or expensive, though a P/E in the low teens can often be considered moderate for a growing sector. The Net Asset Value (NAV) of ₹18.21 per share, compared to the issue price of ₹122, suggests a significant premium to book value, which is common for companies with strong return ratios. Financially, Simran Agrovet exhibits a notable return on net worth (RONW) of 50.95% and a robust return on capital employed (ROCE) of 68.79%.
These high figures indicate efficient utilization of shareholder funds and capital, respectively, suggesting a quality business. However, the EBITDA margin at a modest 2.62% might suggest lower operational efficiency or intense pricing competition within its segment, despite healthy overall profitability. The revenue of ₹566.31 Cr and PAT of ₹11.13 Cr show a PAT margin of approximately 1.96%, which is also on the lower side.
The growth outlook, based solely on the provided snapshot, is positive given the strong return ratios, implying the company can generate substantial profits from its assets. The entirely fresh issue structure also signals a focus on expansion. Key risks include the inherent volatility of the agrochemical sector, which is subject to monsoons and government policies.
The relatively low EBITDA margin could be a persistent challenge impacting operational profitability. As an SME IPO, the track record might be less extensive than larger listed entities, and market liquidity could be lower post-listing. Subscription sentiment, if available, would offer further insights into investor demand and perceived value.
Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Simran Agrovet IPO — Pros & Cons
Strengths
- The company exhibits exceptionally strong return ratios with RONW at 50.95% and ROCE at 68.79%. These high figures indicate efficient management of shareholder funds and capital, suggesting a business with strong profitability and asset utilization capabilities.
- The IPO is structured as a 100% fresh issue, meaning all proceeds will be infused into the company for growth. This signals management's commitment to expansion and provides capital for future development and strategic initiatives.
- Simran Agrovet has achieved a substantial revenue of ₹566.31 Cr, indicating a significant operational scale and established market presence. This scale provides a solid foundation for future growth and diversification within the agrochemical sector.
- The P/E ratio of 13.15x, based on an EPS of ₹9.28, appears to be within a reasonable range for a company in the essential agrochemical sector. This potentially offers investors an entry point at a moderate valuation, assuming consistent future performance.
- The face value of ₹10 per share, with a price band of ₹122, suggests a premium valuation, which is often justified by strong profitability and growth prospects. Investors are essentially paying for the company's earnings potential and future expansion.
Risks
- The company's EBITDA margin is reported at a relatively low 2.62%, which could indicate pressure on operational profitability or intense competition within its specific market segment. This might limit the scope for significant improvement in operating efficiency.
- The PAT margin, calculated at approximately 1.96% (₹11.13 Cr PAT on ₹566.31 Cr Revenue), is also on the lower side. This suggests that while the company is profitable, a significant portion of its revenue is consumed by operating and other expenses.
- The lot size being listed as 0 shares is an anomaly and needs clarification, as it implies no minimum investment unit for retail investors. This unusual data point raises questions about the IPO's structure and accessibility for typical retail applications.
- As an SME IPO, Simran Agrovet may have a shorter operating history or less extensive public financial disclosures compared to mainboard companies. This limited track record can increase investment uncertainty and potential risks for investors.
- The price band of ₹122 per share, coupled with a Net Asset Value (NAV) of ₹18.21, indicates a Price-to-Book (P/B) ratio of approximately 6.7x. While justified by high RONW/ROCE, this premium to book value requires sustained strong performance to be validated.
Simran Agrovet IPO Details
| Company Name | Simran Agrovet |
|---|---|
| IPO Type | SME |
| Exchange | NSE |
| Price Band | ₹122 - ₹122 |
| Face Value | ₹10 per share |
| Lot Size | TBA |
| Total Issue Size | ₹6,435,000.00 Cr |
|---|---|
| Fresh Issue | ₹6,435,000.00 Cr |
| Registrar | 9.28 |
| IPO Status | Upcoming |
Simran Agrovet IPO Dates
Simran Agrovet IPO GMP Today
The Grey Market Premium (GMP) for Simran Agrovet IPO is not available.
Simran Agrovet IPO — Key Highlights
- Simran Agrovet's IPO is a 100% fresh issue, aiming to raise ₹6435000 Cr, indicating capital infusion for company growth.
- The company boasts impressive return ratios, with RONW at 50.95% and ROCE at 68.79%, signifying efficient capital utilization.
- With revenues reaching ₹566.31 Cr, Simran Agrovet operates at a significant scale within the Indian agrochemical sector.
- The IPO is priced at ₹122 per share, offering a P/E ratio of 13.15x based on an EPS of ₹9.28.
- The company's EBITDA margin is reported at a modest 2.62%, suggesting potential operational efficiency challenges.
- The Net Asset Value (NAV) stands at ₹18.21 per share, indicating a substantial premium to book value at the IPO price.
Simran Agrovet Financial Performance
| Metric (₹ Cr) | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Revenue | 87.87 | 368.68 | 566.31 |
| Expenses | 88.73 | 361.17 | 552.95 |
| Net Income (PAT) | 0.78 | 7.17 | 11.13 |
| Margin (%) | 0.89% | 1.94% | 1.97% |
Simran Agrovet IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹9.28 |
|---|---|
| P/E Ratio | 13.15x |
| NAV | ₹18.21 |
| Current Ratio | 1.12 |
| Debt/Equity | 0.730 |
Return Metrics
| RONW (%) | 50.95% |
|---|---|
| ROCE (%) | 68.79% |
| EBITDA Margin | 2.62% |
Simran Agrovet IPO Anchor Investors
| Bid Date | Coming soon |
|---|---|
| Shares Offered | Coming soon |
| Anchor Portion (INR Cr.) | Coming soon |
| Anchor lock-in period end date for 50% shares (30 Days) | Coming soon |
| Anchor lock-in period end date for remaining shares (90 Days) | Coming soon |
Simran Agrovet IPO Lead Manager & Registrar
IPO Registrar
9.28
Simran Agrovet IPO — Frequently Asked Questions
What is Simran Agrovet IPO GMP today?
As of today, the Grey Market Premium (GMP) for Simran Agrovet IPO is not available at this time. GMP values are updated daily based on grey market activity.
What is the price band and lot size of Simran Agrovet IPO?
Simran Agrovet IPO has a price band of ₹122 to ₹122 per equity share with a face value of ₹10. The minimum lot size is 0 shares, requiring a minimum investment of ₹0 at the upper band.
What are the important dates for Simran Agrovet IPO?
Simran Agrovet IPO opens for subscription on TBA and closes on TBA.
How can I apply for Simran Agrovet IPO?
You can apply for Simran Agrovet IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is 9.28.
What is Simran Agrovet IPO price band and lot size?
The Simran Agrovet IPO has a fixed price band of ₹122 per share. The listed lot size is 0 shares, which is an unusual data point and may require further clarification from the company or registrar. The face value of each share is ₹10. Given the unusual lot size, the minimum investment amount is effectively ₹0, and retail investors would typically apply for a single lot or multiple lots based on standard IPO application procedures, if the lot size were defined.
Is Simran Agrovet IPO worth investing in?
Simran Agrovet presents a mixed financial profile. Its strengths lie in robust return ratios (RONW of 50.95% and ROCE of 68.79%) and a substantial revenue base of ₹566.31 Cr, coupled with a 100% fresh issue for growth. However, concerns exist regarding its low EBITDA margin (2.62%) and PAT margin (approx. 1.96%), suggesting operational efficiency challenges or high competition. The P/E of 13.15x seems moderate. Investors should weigh these factors carefully. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Simran Agrovet IPO GMP today?
Grey Market Premium (GMP) for the Simran Agrovet IPO is not publicly available or officially recognized. GMP is an unofficial indicator of demand and is highly speculative. While it can sometimes reflect market sentiment, it should not be the sole basis for investment decisions. Investors should focus on the company's fundamentals and the IPO's official details rather than relying on unofficial market indicators.
How to apply for Simran Agrovet IPO?
To apply for the Simran Agrovet IPO, investors can use the UPI mechanism through their stockbroker's trading application or the ASBA (Application Supported by Blocked Amount) facility via their net banking portal. The registrar for the IPO is listed as 9.28. Funds will remain blocked in your bank account until the shares are allotted. Ensure you have a Demat account and are registered with your broker for IPO applications.